Your browser doesn't support javascript.
loading
Increased efficacy of a dendritic cell-based therapeutic cancer vaccine with adenosine receptor antagonist and CD73 inhibitor.
Arab, Samaneh; Kheshtchin, Nasim; Ajami, Maryam; Ashurpoor, Mahbubeh; Safvati, Aida; Namdar, Afshin; Mirzaei, Reza; Mousavi Niri, Neda; Jadidi-Niaragh, Farhad; Ghahremani, Mohammad Hossein; Hadjati, Jamshid.
Afiliación
  • Arab S; 1 Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Kheshtchin N; 2 Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Ajami M; 3 Department of Immunology, Tarbiat Modares University, Tehran, Iran.
  • Ashurpoor M; 4 Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Safvati A; 2 Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Namdar A; 2 Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Mirzaei R; 2 Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Mousavi Niri N; 5 Department of Biotechnology, Faculty of Advanced Medical Sciences, Tehran Medical Branch, Islamic Azad University, Tehran, Iran.
  • Jadidi-Niaragh F; 4 Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Ghahremani MH; 6 Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Hadjati J; 7 Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Tumour Biol ; 39(3): 1010428317695021, 2017 Mar.
Article en En | MEDLINE | ID: mdl-28349824

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / 5'-Nucleotidasa / Vacunas contra el Cáncer / Receptor de Adenosina A2A / Antagonistas de Receptores Purinérgicos P1 / Neoplasias Experimentales Límite: Animals / Female / Humans Idioma: En Revista: Tumour Biol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / 5'-Nucleotidasa / Vacunas contra el Cáncer / Receptor de Adenosina A2A / Antagonistas de Receptores Purinérgicos P1 / Neoplasias Experimentales Límite: Animals / Female / Humans Idioma: En Revista: Tumour Biol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Países Bajos